Category Archives: Myocardial Infarction

This article was originally published here Patient Relat Outcome Meas. Continue reading →

This article was originally published here Stroke Vasc Neurol. 2020 Oct 30:svn-2020-000503 Continue reading →

Med-Tech Innovation News spoke to Kathleen Orland, senior vice president and general manager for Beckman Coulters clinical chemistry immunoassay about the key role of Access hsTnI assayto detect at-risk patients earlier and discharge non-acute patients faster. Continue reading →

The latest published an effective statistical data titled as Myocardial Infarction Drug Market. It defines about the recent innovations, applications and end users of the market Continue reading →

Global Myocardial Infarction Treatment Market report provides pinpoint analysis for changing competitive dynamics. Continue reading →

Online Drug stores Get Chance of 20% Extra Discount, If your Company is Listed in Above Key Players List; https://inforgrowth.com/discount/2146917/myocardial-infarction-therapeutics-market Impact of COVID-19: Myocardial Infarction Therapeutics Market report analyses the impact of Coronavirus (COVID-19) on the Myocardial Infarction Therapeutics industry. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 180+ countries around the globe with the World Health Organization declaring it a public health emergency Continue reading →

NIJMEGEN, The Netherlands, November 04, 2020Saillant Therapeutics, an innovative preclinical stage biotechnology company developing promising small molecule-based therapies, today announced that it has obtained Proof of Concept for its lead compound (ST02) indicated for the treatment of heart failure. Continue reading →

Patients with obstructive coronary artery disease (CAD) or coronary spasm who experienced a nonfatal cardiac arrest outside the hospital setting and subsequently had a normal electrophysiologic study (EPS) were found to have excellent prognosis, according to a small case series published in the Journal of the American College of Cardiology. Investigators sought to examine the prognosis of patients with confirmed ventricular tachycardia (VT) or ventricular fibrillation (VF) who had survived cardiac arrest after resuscitative efforts and for whom VT or VF inducibility was not observed in EPS. Of 96 out of hospital cardiac arrest survivors who underwent EP testing at a single hospital, 19, all of which were in VF or ventricular flutter during resuscitation without evidence of acute myocardial infarction did not exhibit abnormalities in EPS Continue reading →

This article was originally published here Circ Cardiovasc Interv. 2020 Nov 3:CIRCINTERVENTIONS120009654. doi: 10.1161/CIRCINTERVENTIONS.120.009654. Continue reading →

This article was originally published here Am J Cardiol. 2020 Oct 31:S0002-9149(20)31181-4 Continue reading →